Lawmakers Question Makers on Key Vytorin Meeting
WASHINGTON (Reuters) - Two U.S. Democrats said on Friday
their investigation had raised questions about how Merck & Co
Inc <MRK.N> and Schering-Plough Corp <SGP.N> documented a key
meeting about a controversial study of their Vytorin
cholesterol drug.
